Member Exclusive

Mass spectrometry reveals incorrect drug binding in anti-HIV drugs

Researchers from the University of Oxford (UK) have used mass spectrometry to demonstrate incorrect protein binding in anti-HIV protein inhibitor drugs, which results in unwanted side effects.

Go to the profile of Peter Brown
Aug 31, 2016
1
1

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

1 Comments

Go to the profile of Stella Bennett
Stella Bennett about 1 year ago

It's great that more research is being done into the efficacy of anti-HIV drugs. Any therapeutic for a chronic condition should have as few side effects as possible! Could also have important implications for future drug design.